Objective

UPMC Central Pennsylvania performed a three-month comparison before and after the implementation of EndoTool IV insulin dosing software at one hospital. The analysis focused on patients treated for hyperglycemic and Diabetic Ketoacidosis, excluding COVID patients due to their smaller representation in the patient population after EndoTool IV implementation.

Setting

UPMC Central Pennsylvania, a prominent healthcare institution, includes seven acute care hospitals, providing a total of 1,160 licensed beds.

Results

Data shows a decreased time on insulin infusion, decreased overall LOS, improved time to goal, decreased number of glucose checks and a four-fold decrease in hypoglycemic events.

What does this mean for nursing?

• Decreased cognitive burden and task workload
• Eliminated the need for nurses to interpret titration instructions
• 46% decrease in blood glucose checks
• Spent less time caring for a patient on an insulin infusion – decreasing time on infusion by about 17 hours per patient
• Treated significantly fewer patients for hypoglycemia

What does this mean for the patient?

• Fewer blood glucose checks
• Decreased risk of hypoglycemia
• Decreased LOS in the hospital

Conclusions

The four-fold decrease in hypoglycemic events showcases not only the effectiveness of EndoTool IV to improve patient outcomes but the platforms potential to revolutionize insulin dosing workflows for nurses in hospitalized settings. For the nursing staff, this advancement translates into reduced workloads, lowered cognitive burdens, and more streamlined processes, allowing them to provide better patient-centered care.